Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "activity"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Showing
1
-
8
of
8
Search:
'"activity"'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Clinical review report: Apomorphine (Movapo) (Paladin Labs, Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Motor
Activity
/ drug effects...
”
Read Now
2
Common drug review new combination product submission: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Symtuza) : (Janssen Canada Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antiretroviral Therapy, Highly
Active
...
”
Read Now
3
Clinical review report: Bictegravir/Emtricitabine/Tenofovir alafenamide (B/FTC/TAF) (Biktarvy) (Gilead Sciences Canada, Inc.) : indication : a complete regimen for the treatment of...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antiretroviral Therapy, Highly
Active
...
”
Read Now
4
Common drug review new combination product submission: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Symtuza) : (Janssen Canada Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antiretroviral Therapy, Highly
Active
...
”
Read Now
5
Clinical review report: Bictegravir/Emtricitabine/Tenofovir alafenamide (B/FTC/TAF) (Biktarvy) (Gilead Sciences Canada, Inc.) : indication : a complete regimen for the treatment of...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antiretroviral Therapy, Highly
Active
...
”
Read Now
6
Pharmacoeconomic review report: Emtricitabine/tenofovir alafenamide (Descovy)
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antiretroviral Therapy, Highly
Active
/ economics...
”
Read Now
7
Pharmacoeconomic review report: Emtricitabine/tenofovir alafenamide (Descovy)
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antiretroviral Therapy, Highly
Active
/ economics...
”
Read Now
8
Pharmacoeconomic review report: Dolutegravir (Tivicay)
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antiretroviral Therapy, Highly
Active
/ economics...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
610 - Medicine & health
5
330 - Economics
3
Language
English
8
Collection
National Center for Biotechnology Information
8
Author
Canadian Agency for Drugs and Technologies in Health
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=%22activity%22&type=Subject
Send by Email
×
Loading...